FDA Clears First Generic of Isoproterenol (Isuprel) FDA Clears First Generic of Isoproterenol (Isuprel)

Nexus Pharmaceuticals ' version of the cardiac injection drug isoproterenol hydrochloride received expedited FDA review as a potential first generic.FDA Approvals

Source: Medscape Cardiology Headlines - August 11, 2017 Category: Cardiology Tags: Cardiology News Alert Source Type: news